127 related articles for article (PubMed ID: 385213)
1. [DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial].
Bonzi G; Reguzzoni G; Rocca F; Negri L
Clin Ter; 1979 Apr; 89(2):187-96. PubMed ID: 385213
[No Abstract] [Full Text] [Related]
2. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
Battocchio F; Negri L; Tacchettti G
Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
[No Abstract] [Full Text] [Related]
3. [Study of a new synthetic spasmolytic (DA 3177) in emergency medicine].
Del Fabbro L; Di Bartolomeo C; Grassi L; Lestuzzi A; Perraro F; Tosolini G
Clin Ter; 1977 Dec; 83(6):609-23. PubMed ID: 343975
[No Abstract] [Full Text] [Related]
4. Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects.
Bader F
Pharmatherapeutica; 1986; 4(7):422-8. PubMed ID: 3515369
[TBL] [Abstract][Full Text] [Related]
5. [Clinical experimentation with pentanobornamide, a new synthetic spasmolytic].
Miracco A; Peluso C
Clin Ter; 1970 Mar; 52(6):557-63. PubMed ID: 4916457
[No Abstract] [Full Text] [Related]
6. Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.
Ferrari A; Cavallero M; Spandre M; Gemme C; Rossini FP; Imbimbo BP
Clin Ther; 1986; 8(3):320-8. PubMed ID: 3521859
[TBL] [Abstract][Full Text] [Related]
7. [Results of treatments with the phytopharmaceuticals bilicura and spasmobilicura in disorders of the liver-bile-digestive system].
Gracza L; Gracza E
Fortschr Med; 1977 Dec; 95(47-48):2829-31. PubMed ID: 590909
[No Abstract] [Full Text] [Related]
8. [A new long-lasting anticholinergic drug in gastroduodenal pathology].
Pergola F
Med Chir Dig; 1977; 6(2):105-7. PubMed ID: 875504
[No Abstract] [Full Text] [Related]
9. [Clinical use of prifinium bromide: a new spasmolytic agent].
Marini U; Spotti D; Visconti P
Clin Ter; 1978 Nov; 87(4):367-74. PubMed ID: 36254
[No Abstract] [Full Text] [Related]
10. [Clinical trials of a combination of an original gastric demulcent and a synthetic anticholinergic agent].
Evreux M; Jenoudet L
Lyon Med; 1972 Jun; 227(11):1181-4. PubMed ID: 4564809
[No Abstract] [Full Text] [Related]
11. Double blind trial of trimebutine in the irritable bowel syndrome.
Fielding JF
Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
[No Abstract] [Full Text] [Related]
12. A double-blind study of an oxazepam hemisuccinate-hexadiphane combination in management of gastrointestinal disorders.
Strumia E; Babbini M
Curr Ther Res Clin Exp; 1971 Apr; 13(4):251-6. PubMed ID: 4995695
[No Abstract] [Full Text] [Related]
13. Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.
Camarri E
Curr Med Res Opin; 1986; 10(1):52-7. PubMed ID: 3516580
[TBL] [Abstract][Full Text] [Related]
14. [Clinical trial of a new synthetic anticholinergic: 1290 CERM].
Herne N; Parneix Y
Mars Med; 1969; 106(7):628-30. PubMed ID: 5399370
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation of a new gastroenterotrophic, spasmolytic and antacid combination (Gefarmil compositum)].
Rovera R; Furlotti MG
Minerva Gastroenterol; 1970; 16(4):191-8. PubMed ID: 4930898
[No Abstract] [Full Text] [Related]
16. [Treatment of some functional disorders of the digestive system: clinical experimentation with comparison of a medazepam-metoclopramide combination with medazepam-anticholinergic agent combination].
Natale L
Clin Ter; 1975 Jan; 72(2):141-57. PubMed ID: 3308
[No Abstract] [Full Text] [Related]
17. Anisotropine methylbromide for relief of gastrointestinal spasm: double-blind crossover comparison study with belladonna alkaloids and phenobarbital.
King JC
Curr Ther Res Clin Exp; 1966 Nov; 8(11):535-41. PubMed ID: 4962781
[No Abstract] [Full Text] [Related]
18. [Controlled clinical study of the oral use of Ketoscilium in dyskinetic-spastic disorders of the digestive tract].
Maduli S; Frigerio G
Minerva Gastroenterol; 1970; 16(2):94-8. PubMed ID: 5477402
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of a new digestivo-spasmolytic agent].
Glassman J; Odzak A
Prensa Med Argent; 1966 Sep; 53(37):2033-5. PubMed ID: 5993479
[No Abstract] [Full Text] [Related]
20. Antalgic properties of proxazole. Double blind study in visceral algoplastic conditions.
De Gregorio M; Damiani S; Gatta G
Panminerva Med; 1969 Sep; 11(9):436-40. PubMed ID: 4901029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
